No Data
Earnings Preview: AUPH to Report Financial Results Pre-market on November 07
Aurinia Pharmaceuticals to Release Third Quarter Financial and Operational Results on November 7, 2024
Even After Rising 5.9% This Past Week, Aurinia Pharmaceuticals (NASDAQ:AUPH) Shareholders Are Still Down 77% Over the Past Three Years
Axonis Therapeutics Announces $115 Million Series A Financing
Aurinia To Present Six Abstracts, Including Five Poster Presentations, At The American Society Of Nephrology Kidney Week 2024 Taking Place In San Diego, October 23-27
Aurinia Presents New Data Highlighting Real-World Utilization and Value of LUPKYNIS in Treating Lupus Nephritis at American Society of Nephrology Kidney Week 2024